PLEASE TELL US A LITTLE ABOUT YOURSELF SO THAT WE CAN DISPLAY THE MOST
APPROPRIATE CONTENT TO YOU:

This site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about cookies used on Trustnet and how you can manage them, see our Privacy and Cookie Policy.

By clicking "I Agree" below, you acknowledge that you accept our Privacy Policy and Terms of Use.

For more information Click here

Login

Password Reminder
Not Registered? Click Here

Register

Register
It's look like you're leaving us

What would you like us to do with the funds you've selected

Show me all my options Forget them Save them
Customise this table
You are here: Manager factsheet

Evan McCulloch
Franklin Temp Intnl Serv SARL
pdfIcon Manager factsheet pdf    rss feed RSS Feed
Manager profile
Evan McCulloch is a vice president, portfolio manager and analyst for Franklin Equity Group. Mr. McCulloch is the lead portfolio manager of Franklin Biotechnology Discovery Fund. He is also the health care sector team leader. Mr. McCulloch specialises in research analysis of biotechnology and emerging pharmaceutical companies, with a therapeutic focus on infectious diseases, ophthalmology, pulmonology, cardiovascular disease, gastroenterology and the central nervous system. Prior research coverage includes the pharmaceutical, medical technology and healthcare service sectors. Mr. McCulloch joined Franklin Templeton Investments in 1992. He earned his B.A. in economics from the University of California at Berkeley. He is a Chartered Financial Analyst (CFA) Charterholder, and a member of the CFA Institute and the Security Analysts of San Francisco (SASF).
Total return for Evan McCulloch
Manager career performance
Discrete calendar year performance : Evan McCulloch

Manager career performance
Discrete performance
  0-12m 12-24m 24-36m 36-48m 48-60m 60-72m 72-84m 84-96m 96-108m 108-120m
Evan McCulloch -14.4 27.7 3.1 -17.1 25.3 3.3 11.9 -7.3 39.9 -28.1
Peer Group Composite -8.5 6.3 -0.7 -1.4 27.8 1.6 16.7 -3.6 27.4 -14.9
Over / Under -5.9 21.4 3.8 -15.7 -2.5 1.7 -4.8 -3.7 12.5 -13.2
Performance vs peer group composite: Evan McCulloch
How a manager matches up against their peers gives you some idea of how talented they are. Very few managers perform equally well in rising and falling markets, so knowing which type of market a manager is capable of performing well within is also important.
 
Overall markets
Up
Outperformed peer group composite
4 years
out of a possible 10
 
Overall markets
Up
Underperformed peer group composite
6 years
out of a possible 10
 
Rising markets
UpDown
Outperformed peer group composite
3 years
out of a possible 5
 
Falling markets
UpDown
Outperformed peer group composite
1 year
out of a possible 5
Funds currently managed
Fund Sole/Co-managed Sector Periods
Franklin Biotechnology Discovery Co-managed FO Equity - Pharma Health & Biotech since Nov 01 2000 to present
Funds managed previously
Fund Periods
FTF Franklin Biotechnology since Nov 01 2000 to fund close
Franklin Templeton Franklin Life Science Discovery since Jun 26 2000 to fund close
News & Research: Related articles sector Sector fund Fund group Group manager Manager
Group The cheapest funds for cost-conscious investors in 2025 By Jonathan Jones  11-Mar-2025
Group Fidelity dominates the list of Asia Pacific’s long-term heroes who are currently struggling By Matteo Anelli  06-Feb-2025
Data provided by FE fundinfo. Care has been taken to ensure that the information is correct, but FE fundinfo neither warrants, represents nor guarantees the contents of information, nor does it accept any responsibility for errors, inaccuracies, omissions or any inconsistencies herein. Past performance does not predict future performance, it should not be the main or sole reason for making an investment decision. The value of investments and any income from them can fall as well as rise.

LATEST :

Five reasons to keep hold of your defensive funds

13:00 | Monday, January 20, 2014

Close

You are currently using an old browser which will not be supported by Trustnet after 31/07/2016. To ensure you benefit from all features on the site, please update your browser.   Close

© Trustnet Limited 2025. All Rights Reserved.
Please read our Terms of Use / Disclaimer and Privacy and Cookie Policy.
Data supplied in conjunction with Refinitiv and London Stock Exchange Plc